Title |
Further in vitro evaluation of antimicrobial activity of the marine sesquiterpene hydroquinone avarol.
|
---|---|
Published in |
Current Pharmaceutical Biotechnology, January 2014
|
DOI | 10.2174/138920101506140910152253 |
Pubmed ID | |
Authors |
Boris Pejin, Carmine Iodice, Giuseppina Tommonaro, Bojana Stanimirovic, Ana Ciric, Jasmina Glamoclija, Milos Nikolic, Salvatore De Rosa, Marina Sokovic |
Abstract |
This work extends in vitro screening of antimicrobial activity of the sesquiterpene hydroquinone avarol, a main secondary metabolite of the Mediterranean sponge species Dysidea avara. The antimicrobial activity was in part evaluated by microdilution method against selected bacterial and fungal strains. Additionally, the screening included evaluation of anti-quorum sensing (anti-QS) effects. At a different extent avarol was proven to be active against all the microorganisms tested (MIC 0.002-0.008 mg/mL and MBC 0.004-0.016 mg/mL; MIC 0.004-0.015 mg/mL and MFC 0.008-0.030 mg/mL; respectively). This marine natural product also showed moderate anti-QS effects, reducing Pseudomonas aeruginosa PAO1 biofilm formation (75%), its twitching and protrusions motilities as well as pyocianin production (39%). According to the best of our knowledge, this is the first report both on avarol anti Gram-negative bacterial activity and anti-QS effects. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 4% |
United States | 1 | 4% |
Serbia | 1 | 4% |
Unknown | 21 | 88% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 25% |
Student > Ph. D. Student | 4 | 17% |
Student > Master | 3 | 13% |
Student > Doctoral Student | 2 | 8% |
Professor | 2 | 8% |
Other | 3 | 13% |
Unknown | 4 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 8 | 33% |
Immunology and Microbiology | 3 | 13% |
Biochemistry, Genetics and Molecular Biology | 2 | 8% |
Chemistry | 2 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Other | 4 | 17% |
Unknown | 4 | 17% |